CEO corner

Interview with Dr James Garner, CEO of Kazia Therapeutics

XR-17 is Vivesto’s proprietary delivery platform

Vivesto published its Q3 report for 2023 on November 16, 2023, at 08.00 am CET.

The Share

Annual Report 2022